{"data":{"id":"us-in/ic-25-26-24-12.5","jurisdiction":"us-in","citation":"IC 25-26-24-12.5","heading":"\"Prescription drug monitoring program data\"","body":"Sec. 12.5. \"Prescription drug monitoring program data\", for purposes of section 19 of this chapter, means the following:\n(1) Information received under section 17 of this chapter, including clinical or required alerts as defined by the board.\n(2) Any other information determined by the board, including:\n(A) a report concerning controlled substance poisonings or overdoses; and\n(B) information concerning participation in an opioid treatment program (as defined in IC 12-7-2-135.6).","path":["TITLE 25. PROFESSIONS AND OCCUPATIONS","ARTICLE 26. PHARMACISTS, PHARMACIES, DRUG STORES","Chapter 24. Central Repository for Controlled Substances Data"],"source_url":"https://iga.in.gov/ic/2026/Title_25.html#25-26-24-12.5","current_through":"2026","vintage":"2026","retrieved_at":"2026-10-06T20:43:28Z","sha256":"76a126db9aec17a1854c3f828fb2b282241ebacb22ce66ffe36b9eaf23b087fd","source_id":"us-in","stale":false,"prev":"us-in/ic-25-26-24-12","next":"us-in/ic-25-26-24-13"},"notice":"GroundRules: Original legal text. Not legal advice."}